通过比较方法来确定本地晚期宫癌患者对化学辐射的完整反应
Kim van Kol1,2, Renée Ebisch3, Maaike Beugeling4
1Department of Obstetrics and Gynecology, Catharina Cancer Institute, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
Cancers
|January 11, 2024
概括
磁共振成像 (MRI) 是推的成像技术,用于检测化学放射治疗 (CRT) 后残留的宫癌. 结合MRI与18F-FDG-PET/CT并不能提高局部区域残留疾病的诊断准确度.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 医疗成像医学成像
背景情况:
- 化疗放射治疗 (CRT) 是局部晚期宫癌的标准治疗方法.
- 确定CRT后的完全缓解对于患者的管理和预后至关重要.
- 对于评估治疗反应的最佳成像方法缺乏共识.
研究的目的:
- 评估MRI和18F-FDG-PET/CT在检测宫癌CRT后的局部区域残留疾病的诊断性能.
- 为了比较单个成像技术与其组合的准确性.
主要方法:
- 用CRT治疗的局部晚期宫癌患者 (FIGO 2009) 的回顾性分析.
- 评估MRI和18F-FDG-PET/CT准确度,使用组织学作为参考标准.
- 计算每个成像模式及其组合的负和正预测值.
主要成果:
- 综合MRI和18F-FDG-PET/CT显示局部残留疾病的诊断性能有限 (NPV 84.2%,PPV 70.4%).
- 仅MRI就产生了80.2%的NPV和47.7%的PPV.
- 仅18F-FDG-PET/CT就产生了81.1%的NPV和55.8%的PPV.
结论:
- 在CRT后检测残留子宫癌时,MRI和18F-FDG-PET/CT的诊断可靠性有限.
- 结合MRI和18F-FDG-PET/CT并不能提高残留疾病检测的预测值.
- 磁力共振成像 (MRI) 是对随访的首选成像技术,在抢救手术前建议进行组织学确认.
关键词:
18F[FDG]-PET/CT/CT/CT-PET/CT/CT 18F[FDG]-PET/CT/CT 18F[FDG]-PET/CT 18F[FDG]-PET/CT 18F[FDG]-PET/CT 18F[FDG]-PET/CT 18F[FDG]-PET/CT 18F[FDG]-PET/CT 18F[FDG]-PET/CT 18F[PET/CT] 18F[PET/CT]-PET/CT 18F[PET/CT] 18F[PET/CT]-PET/CT这就是为什么MRI是MRI.化学疗法或放射治疗局部晚期的宫癌.放射性成像 放射性成像 放射性成像这种残留疾病的残留疾病是残留疾病.抢救手术是救援手术.幸存率 幸存率 生存率更多相关视频
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
290
相关概念视频
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
